{
    "clinical_study": {
        "@rank": "43458", 
        "acronym": "THN2", 
        "arm_group": {
            "arm_group_label": "aura6000 THN Therapy", 
            "arm_group_type": "Experimental", 
            "description": "The aura6000 THN system will be implanted and activated for nightly therapy during sleep."
        }, 
        "brief_summary": {
            "textblock": "The objective of the study is to confirm the safety and efficacy in patients utilizing the\n      aura6000 System for the treatment of Obstructive Sleep Apnea (OSA)."
        }, 
        "brief_title": "Targeted Hypoglossal Neurostimulation Study #2", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Sleep Apnea Syndromes", 
            "Sleep Apnea, Obstructive", 
            "Respiration Disorders", 
            "Signs and Symptoms, Respiratory", 
            "Syndrome, Obstructive Sleep Apnea"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Apnea", 
                "Respiration Disorders", 
                "Signs and Symptoms", 
                "Signs and Symptoms, Respiratory", 
                "Sleep Apnea Syndromes", 
                "Sleep Apnea, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  AHI >20\n\n          -  Noncompliant to CPAP\n\n          -  Willing to provide informed consent\n\n          -  Willing to comply with all follow-up visits and evaluations\n\n        Exclusion Criteria:\n\n          -  BMI limits\n\n          -  COPD\n\n          -  Central Sleep Apnea\n\n          -  Anatomic variations interfering with device placement or stability."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01796925", 
            "org_study_id": "IMT2012-02"
        }, 
        "intervention": {
            "arm_group_label": "aura6000 THN Therapy", 
            "description": "The aura6000 device is an implanted hypoglossal nerve stimulator designed to maintain wakeful muscle tone of the tongue during sleep. It is implanted through a short surgical procedure. The implant is programmed to provide the optimal stimulation parameters for the patient. The therapy is controlled by a hand-held remote control allowing the patient to start, stop, and pause the therapy during times of sleep.", 
            "intervention_name": "aura6000 THN System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Apnea", 
            "Respiration Disorders", 
            "Signs and Symptoms", 
            "Signs and Symptoms, Respiratory", 
            "Sleep Apnea Syndromes", 
            "Sleep Apnea, Obstructive", 
            "Respiratory Tract Diseases", 
            "Sleep Disorders, Intrinsic", 
            "Sleep Disorders", 
            "Nervous System Diseases"
        ], 
        "lastchanged_date": "September 10, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92123"
                    }, 
                    "name": "Sharp Rees Stealy Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80210"
                    }, 
                    "name": "Porter Adventist Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60657"
                    }, 
                    "name": "Chicago ENT"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Middletown", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10940"
                    }, 
                    "name": "Orange Regional Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1200"
                    }, 
                    "name": "Clinique Univ. Saint-Luc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75013"
                    }, 
                    "name": "Piti\u00e9-Salp\u00eatri\u00e8re Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "10117"
                    }, 
                    "name": "Advanced Sleep Research"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bremen", 
                        "country": "Germany", 
                        "zip": "28209"
                    }, 
                    "name": "St. Joseph-Stift"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Forli", 
                        "country": "Italy", 
                        "zip": "47121"
                    }, 
                    "name": "G.B. Morgagni- L. Pierantoni Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Belgium", 
                "France", 
                "Germany", 
                "Italy"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "Clinical Study of the aura6000\u2122 Targeted Hypoglossal Implantable Neurostimulation (THN) Sleep Therapy System", 
        "overall_official": [
            {
                "affiliation": "Clinique Univ. Saint-Luc", 
                "last_name": "Daniel Rodenstein, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hudson Valley ENT", 
                "last_name": "Ofer Jacobowitz, MD PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Belgium: Ethics Committee", 
                "Germany: Ethics Commission", 
                "Italy: Ethics Committee", 
                "France: Institutional Ethical Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Change from baseline in AHI measured through in-lab polysomnography (PSG).", 
                "measure": "Reduction in Apnea-Hypopnea Index (AHI)", 
                "safety_issue": "No", 
                "time_frame": "3, 6, and 12 months post implant"
            }, 
            {
                "description": "Change from baseline in ODI measured through in-lab polysomnography (PSG).", 
                "measure": "Reduction in Oxygen Desaturation Index (ODI)", 
                "safety_issue": "No", 
                "time_frame": "3, 6, and 12 months post implant"
            }, 
            {
                "description": "Adverse events and Serious Adverse events post-operatively", 
                "measure": "Freedom from Serious Adverse Events (SAE)", 
                "safety_issue": "Yes", 
                "time_frame": "1 and 12 months post implant"
            }
        ], 
        "reference": [
            {
                "PMID": "22938390", 
                "citation": "Zaidi FN, Meadows P, Jacobowitz O, Davidson TM. Tongue anatomy and physiology, the scientific basis for a novel targeted neurostimulation system designed for the treatment of obstructive sleep apnea. Neuromodulation. 2013 Jul-Aug;16(4):376-86; discussion 386. doi: 10.1111/j.1525-1403.2012.00514.x. Epub 2012 Aug 31."
            }, 
            {
                "PMID": "22599356", 
                "citation": "Mwenge GB, Rombaux P, Dury M, Lengel\u00e9 B, Rodenstein D. Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study. Eur Respir J. 2013 Feb;41(2):360-7. doi: 10.1183/09031936.00042412. Epub 2012 May 17."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01796925"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Mean change in microarousal index as compared to baseline.", 
                "measure": "Improvement in sleep fragmentation", 
                "safety_issue": "No", 
                "time_frame": "3, 6, and 12 months post-implant"
            }, 
            {
                "description": "Mean change in SAQLI (Sleep Apnea Quality of Life Index) as compared to baseline.", 
                "measure": "Improvement in SAQLI", 
                "safety_issue": "No", 
                "time_frame": "3, 6, and 12 months post implant"
            }, 
            {
                "description": "Mean change in ESS (Epworth Sleepiness Scale) as compared to baseline.", 
                "measure": "Improvement in ESS", 
                "safety_issue": "No", 
                "time_frame": "3, 6, and 12 months post implant"
            }
        ], 
        "source": "ImThera Medical, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ImThera Medical, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}